Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
TriSalus Life Sciences (TLSI)
NASDAQ:TLSI
RESEARCH TOOLSreports
Holding TLSI?
Track your performance easily
TriSalus Life Sciences (TLSI) Ownership Overview
44.09% Insiders
1.80% Mutual Funds
2.11% Other Institutional Investors
1.36% ETFs
50.64% Public Companies and Individual Investors
The ownership structure of TriSalus Life Sciences (TLSI) stock is a mix of institutional, retail, and individual investors. Approximately 5.27% of the company’s stock is owned by Institutional Investors, 44.09% is owned by Insiders, and 50.64% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
| Jan 29, 2025 | Mary Szela Ceo & President,director | xxxxxxxxxxxxx | $50303 |
| Jan 29, 2025 | Sean Murphy Chief Manuf, Strategy&bus Dev,director | xxxxxxxxxxxxx | $157200 |
| Jan 29, 2025 | James Emmett Young Chief Financial Officer | xxxxxxxxxxxxx | $129600 |
| Dec 19, 2024 | Cox Bryan F. Chief Of Research | xxxxxxxxxxxxx | $1394 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
| Sep 30, 2024 | xxxxxxxxxxxxx | $66568 | |
| Sep 30, 2024 | xxxxxxxxxxxxx | $96136 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 6,230,748 | Insider | 20.43% | 29,907,590 | |
| 2,665,202 | Insider | 8.74% | 12,792,970 | |
| 1,909,729 | Insider | 6.24% | 9,166,699 | |
| 941,944 | Insider | 3.09% | 4,521,331 | |
| 576,055 | Insider | 1.89% | 2,765,064 | |
| 426,921 | Institution | 1.40% | 2,049,221 | |
| 413,965 | Institution | 1.36% | 1,987,032 | |
| 411,002 | Institution | 1.35% | 1,972,810 | |
| 384,677 | Insider | 1.26% | 1,846,450 | |
| 247,176 | Insider | 0.81% | 1,186,445 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 411,002 | Institution | 1.35% | 1,972,810 | |
| 123,597 | Institution | 0.41% | 593,266 | |
| 15,000 | Institution | 0.05% | 72,000 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 248,877 | Institution | 0.82% | 1,134,879 | |
| 165,088 | Institution | 0.54% | 752,801 |
FAQ
Who Owns TriSalus Life Sciences (TLSI)?
According to the latest TipRanks data, approximately 2.11% of the company's stock is held by institutional investors, 44.09% is held by insiders, and 50.64% is held by retail investors.
What percentage of TriSalus Life Sciences (TLSI) stock is held by institutional investors?
According to the latest TipRanks data, approximately 2.11% of TriSalus Life Sciences (TLSI) stock is held by institutional investors.
What percentage of TriSalus Life Sciences (TLSI) stock is held by retail investors?
According to the latest TipRanks data, approximately 50.64% of TriSalus Life Sciences (TLSI) stock is held by retail investors.
Who owns the most shares of TriSalus Life Sciences (TLSI)?
Frankenius Equity AB owns the most shares of TriSalus Life Sciences (TLSI).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.